CCM
XYL icon

CrestPoint Capital Management’s Xylem XYL Stock Holding History

CrestPoint Capital Management’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,700
Closed -$223K – 228
2014
Q2 		$223K Buy
+5,700
New +$213K 0.13% 203

Other funds holding XYL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SC
Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return

CrestPoint Capital Management's XYL Position: Q3 2014 in Review

CrestPoint Capital Management sold out of Xylem (XYL) in Q3 2014, closing a stake of 5,700 shares — an estimated $223K sold.

CrestPoint Capital Management first reported a position in XYL in Q2 2014 and held it in 1 quarter. The position peaked at $223K in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

  • CrestPoint Capital Management reported no remaining Xylem position as of Q3 2014 after selling out during the quarter.
  • CrestPoint Capital Management sold 5,700 Xylem shares in Q3 2014, an estimated $223K.
  • CrestPoint Capital Management first reported a position in Xylem in Q2 2014 and held it in 1 quarter.
  • CrestPoint Capital Management's Xylem position peaked at $223K in Q2 2014.
  • 439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on CrestPoint Capital Management's 13F filing for Q3 2014, filed 10 Oct 2014.